8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2015 / Single-arm pre-post intervention study
Thirty young females with BMI >= 20 drank 280 mL of tomato juice daily (providing 32.5 mg of lycopene) for 2 months while maintaining their normal diet and exercise. Twenty-five participants completed the trial. Supplementation significantly decreased body weight, body fat, waist circumference, BMI, cholesterol, MCP-1, and thiobarbituric reactive substances, while increasing adiponectin, triglyceride, and lycopene levels. Decreases in waist circumference, cholesterol, and MCP-1 and increases in adiponectin and lycopene occurred regardless of whether participants experienced body fat reduction.
Li YF, Chang YY, Huang HC, et al. Nutrition, 2015. PMID 25837214
2014 / Clinical trial (before-after study)
Thirty-five young women (aged 19.6 ± 1.3 years) ingested a raw ripe tomato (~90 g) daily before lunch for 4 weeks. At the end of the 4 weeks, significant reductions were observed in body weight (-1.09 ± 0.12 kg on average), % fat (-1.54 ± 0.52%), fasting blood glucose (-5.29 ± 0.80 mg/dl), triglycerides (-8.31 ± 1.34 mg/dl), cholesterol (-10.17 ± 1.21 mg/dl), and uric acid (-0.16 ± 0.04 mg/dl). The authors noted that pre-meal tomato ingestion seemed to interfere positively in body weight, fat percentage, and these biochemical parameters.
Vinha AF, Barreira SV, Costa AS, et al. Int J Food Sci Nutr, 2014. PMID 25156566
2013 / Randomized controlled trial
In a randomized trial, 106 overweight or obese female students drank 330 ml/day of tomato juice or water for 20 days. Serum IL-8 and TNF-alpha decreased significantly in the tomato juice group compared with baseline and control. In subgroup analysis, IL-8 and TNF-alpha reductions occurred only in overweight participants, whereas obese participants experienced lower IL-6.
Ghavipour M, Saedisomeolia A, Djalali M, et al. Br J Nutr, 2013. PMID 23069270
2011 / Controlled feeding trial
Fifty-five healthy men consumed ad libitum from low-salt and high-salt creamy tomato soup across long, short, and free oral sensory exposure conditions with pump-controlled bites. The short exposure condition led to ~34% higher ad libitum intake compared to the long condition (P < 0.001), with no interaction with salt intensity. High-salt soup intake was ~9% lower than low-salt soup (P < 0.001). Under the free condition, high-salt soup was consumed with smaller bite sizes during the first half of the intake period (P < 0.05).
Bolhuis DP, Lakemond CM, de Wijk RA, et al. J Nutr, 2011. PMID 22049294
1998 / Experimental crossover feeding trial
Nine healthy, fasted men received 425 ml (400 kcal) of tomato soup administered orally, intragastrically (covertly and overtly), or intraduodenally (overtly). Intraduodenal infusion exerted no significant suppression of hunger or desire to eat and no significant fullness. Covert intragastric infusion suppressed appetite, which was further increased when subjects were informed of the infusion, though gastric emptying profiles did not differ between covert and overt gastric infusions. Oral ingestion produced the greatest appetite suppression, slower gastric emptying than intragastric infusions, and the strongest correlations between appetite ratings and gastrointestinal contents.
Cecil JE, Francis J, Read NW Appetite, 1998. PMID 9920689